Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Klimkait

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Virology|November 1, 1987
E1B functions of type C adenoviruses play a role in the complementation of blocked adenovirus type 12 DNA replication and late gene transcription in hamster cellsT Klimkait, W Doerfler
Journal of Virology|August 1, 1985
Adenovirus types 2 and 5 functions elicit replication and late expression of adenovirus type 12 DNA in hamster cellsT Klimkait, W Doerfler
Therapeutische Umschau. Revue Therapeutique|November 10, 2004
[Adherence and resistance]T Klimkait, P Vernazza
Virology|June 1, 1989
A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutationsJ M Felser, T Klimkait, J Silver
The Journal of Infectious Diseases|December 26, 2001
Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathyH H Hirsch, M Mohaupt, T Klimkait
Science (New York, N.Y.)|September 2, 1988
A novel gene of HIV-1, vpu, and its 16-kilodalton productK Strebel, T Klimkait, M A Martin
Journal of Biomolecular Screening|November 2, 2001
Merged screening for human immunodeficiency virus Tat and Rev inhibitorsF Hamy, E Felder, K Lipson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2004
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressureC Suñé, L Brennan, D R Stover, et al.
Journal of Virology|September 1, 1989
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu proteinK Strebel, T Klimkait, F Maldarelli, et al.
Biotechnology and Bioengineering|July 9, 1999
Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structuresT Klimkait, E R Felder, G Albrecht, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Virology|November 1, 1987
E1B functions of type C adenoviruses play a role in the complementation of blocked adenovirus type 12 DNA replication and late gene transcription in hamster cellsT Klimkait, W Doerfler
Journal of Virology|August 1, 1985
Adenovirus types 2 and 5 functions elicit replication and late expression of adenovirus type 12 DNA in hamster cellsT Klimkait, W Doerfler
Therapeutische Umschau. Revue Therapeutique|November 10, 2004
[Adherence and resistance]T Klimkait, P Vernazza
Virology|June 1, 1989
A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutationsJ M Felser, T Klimkait, J Silver
The Journal of Infectious Diseases|December 26, 2001
Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathyH H Hirsch, M Mohaupt, T Klimkait
Science (New York, N.Y.)|September 2, 1988
A novel gene of HIV-1, vpu, and its 16-kilodalton productK Strebel, T Klimkait, M A Martin
Journal of Biomolecular Screening|November 2, 2001
Merged screening for human immunodeficiency virus Tat and Rev inhibitorsF Hamy, E Felder, K Lipson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2004
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressureC Suñé, L Brennan, D R Stover, et al.
Journal of Virology|September 1, 1989
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu proteinK Strebel, T Klimkait, F Maldarelli, et al.
Biotechnology and Bioengineering|July 9, 1999
Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structuresT Klimkait, E R Felder, G Albrecht, et al.
Pageof 6